From: Dose-dependent LDL-cholesterol lowering effect by plant stanol ester consumption: clinical evidence
Reference | Subject characteristics | Treatment characteristics | |||||||
---|---|---|---|---|---|---|---|---|---|
N | Age (years) | Men (%) | weight status | Baseline bloodcholesterol | Study design | Vehicle | Dose of plant stanols (g/d)1 | Duration (wk) | |
[10]Nguyen 1999 | 83 | 49 | 30 | mildly hypercholesterolaemic | open label, dose-response in comparison to respective baselines | margarine, soya yoghurt | 3 / 6 / 10 | 2 | |
[11]Plat & Mensink 2000 | 112 | 33 | 37 | normal | normocholesterolaemic | parallel, randomized, double-blind, placebo-controlled | margarine, shortening for baking | 0 / 3.82 / 43 | 8 |
[12]Cater et al. 2005 | 8 | 58 | 75 | slightly overweight | mildly hypercholesterolaemic | cross-over,randomized, double-blind, placebo-controlled | margarine | 0 / 2 / 3 / 4 | 6 |
[13]Gylling et al. 2010 | 49 | 62 | 35 | slightly overweight | mildly hypercholesterolaemic | parallel, randomized, double-blind, placebo-controlled | margarine, oat based drink | 0 / 8.8 | 10 |
[14]Mensink et al. 2010 | 93 | 56 | 53 | slightly overweight | mildly hypercholesterolaemic | parallel, randomized, double-blind, placebo-controlled | margarine, soya based yoghurt | 0 / 3 / 6 / 9 | 4 |